Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Testa

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
Cancer Biology & Therapy|March 3, 2020
Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinomaAndres F Correa, Karen J Ruth, Tahseen Al-Saleem, et al.
American Journal of Respiratory Cell and Molecular Biology|April 2, 2011
An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injuryArti Shukla, Trisha F Barrett, Maximilian B MacPherson, et al.
Frontiers in Environmental Science|December 3, 2020
Challenging Global Waste Management - Bioremediation to Detoxify AsbestosShannon L Wallis, Edward A Emmett, Robyn Hardy, et al.
International Journal of Cancer|June 10, 2003
SV40 and human brain tumorsMichele Carbone, Maurizio Bocchetta, Alfonso Cristaudo, et al.
Cancer Research|June 2, 2019
Inactivation of <i>Bap1</i> Cooperates with Losses of <i>Nf2</i> and <i>Cdkn2a</i> to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse ModelsAnna-Mariya Kukuyan, Eleonora Sementino, Yuwaraj Kadariya, et al.
Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.
Molecular Cancer Therapeutics|July 29, 2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
Cancer Research|December 28, 2013
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axisCraig W Menges, Yuwaraj Kadariya, Deborah Altomare, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
CD45-deficient severe combined immunodeficiency caused by uniparental disomyJoseph L Roberts, Rebecca H Buckley, Biao Luo, et al.
Genes, Chromosomes & Cancer|July 9, 2009
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumorsMartin G Belinsky, Yuliya V Skorobogatko, Lori Rink, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Cancer Biology & Therapy|March 3, 2020
Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinomaAndres F Correa, Karen J Ruth, Tahseen Al-Saleem, et al.
American Journal of Respiratory Cell and Molecular Biology|April 2, 2011
An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injuryArti Shukla, Trisha F Barrett, Maximilian B MacPherson, et al.
Frontiers in Environmental Science|December 3, 2020
Challenging Global Waste Management - Bioremediation to Detoxify AsbestosShannon L Wallis, Edward A Emmett, Robyn Hardy, et al.
International Journal of Cancer|June 10, 2003
SV40 and human brain tumorsMichele Carbone, Maurizio Bocchetta, Alfonso Cristaudo, et al.
Cancer Research|June 2, 2019
Inactivation of <i>Bap1</i> Cooperates with Losses of <i>Nf2</i> and <i>Cdkn2a</i> to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse ModelsAnna-Mariya Kukuyan, Eleonora Sementino, Yuwaraj Kadariya, et al.
Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.
Molecular Cancer Therapeutics|July 29, 2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
Cancer Research|December 28, 2013
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axisCraig W Menges, Yuwaraj Kadariya, Deborah Altomare, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
CD45-deficient severe combined immunodeficiency caused by uniparental disomyJoseph L Roberts, Rebecca H Buckley, Biao Luo, et al.
Genes, Chromosomes & Cancer|July 9, 2009
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumorsMartin G Belinsky, Yuliya V Skorobogatko, Lori Rink, et al.
Pageof 19